Dr. Vaibhav A. Narayan Joins Davos Alzheimer’s Collaborative as Executive Vice President and Head of Strategy and Innovation
CONTACT: Susan Oliver, soliver@DavosAlzheimersCollaborative.org, 703-216-4078
GENEVA, SWITZERLAND- (July 19, 2022) – The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s diseases, today announced the addition of Vaibhav A. Narayan PhD, MBA, former Vice President of Digital Health innovation at Johnson & Johnson and Head of Data Science for Neuroscience at Janssen, as Executive Vice President and Head of Strategy and Innovation.
Dr. Narayan will lead strategy development for the Collaborative and drive a digital and data driven innovation agenda for the Global Cohort Development Program that is seeking to expand participation in research – from Argentina to Tanzania – to enable value generation for a diverse set of stakeholders including industry partners, academic researchers and ultimately the patients and their caregivers.
“Dr. Narayan’s collaboration as a data scientist and digital health innovator will bolster our efforts” says Rhoda Au, Head, Global Cohort Development Program. “His skills are needed as we build a cohort of 1 million people over the next 5 years to study, treat, and re-imagine Alzheimer’s response.”
Dr. Narayan brings extensive experience in data science, industry collaborations, and innovative digital health leadership. At Johnson & Johnson, Dr. Narayan led programs that utilized multi-modal data from ‘genomics to digital’ to understand disease subtypes and develop AI/ML driven digital health solutions for prevention, early detection and disease course monitoring and prediction in Alzheimer’s and neuropsychiatric diseases.
According to George Vradenburg, Founding Chairman, DAC, and Convener, the Global CEO Initiative on Alzheimer’s Disease: “I know Dr. Narayan will leverage his research expertise and partnerships to build more diverse networks for study. As he joins the team, DAC is better equipped to lead this unprecedented initiative. Dr. Narayan’s addition comes just as DAC is commencing significant expansion of the global cohort program, which is expected to set the model for inclusive research and drug development to better respond to the global increase in the prevalence of Alzheimer’s.”
“I’m thrilled to be joining the DAC team of innovators, changemakers, and scientists, redefining inclusive research tailored for diverse populations,” said Dr. Narayan, “This unprecedented effort is shaping the next generation of research questions and making real impact.”
Prior to J&J, Vaibhav held multiple data science and informatics leadership roles in Biotech and Big Pharma, including 5 years as Head of Computational Sciences at Celera Genomics where he participated in the sequence, assembly, and analysis of the Human Genome. In addition to leadership roles within the industry, Vaibhav has helped form and lead multi-stakeholder innovation ecosystems including large public-private partnerships at the intersection of data science, digital health and neuroscience. (www.linkedin.com/in/vaibhav-phd-mba)
Vaibhav holds multiple patents and has co-authored > 80 scientific publications. Vaibhav obtained his PhD from Yale University and an Executive MBA from Kellogg School of Management, Northwestern University.
About the Davos Alzheimer’s Collaborative
Launched at the World Economic Forum’s 2021 meeting on The Davos Agenda, DAC is a multi-stakeholder partnership committed to aligning stakeholders with a new vision for our collective global response against the challenges that Alzheimer’s presents to patients, caregivers and health care infrastructures. Convened by the World Economic Forum and the Global CEO Initiative on Alzheimer’s Disease (CEOi), and fueled by a mission of service to the estimated 150 million families and half a billion people inevitably impacted by this disease by 2050, DAC is a collaborative for the benefit of all people, in all places.
###